A few studies suggest that BMP6 and HJV, which are inhibited in liver cancer, are the main regulator of hepcidin expression [37,38], while studies have also shown that the low expression of hepcidin predicts poor prognosis in liver cancer patients. Here, HAMP is linked to liver cancer.